Skip to content
Clinical Trials – home
CzechiaBack to Czechia

Clinical trials in Prazske Predmesti

13 clinical trials in Prazske Predmesti, Czechia. Every trial is listed in the EU Clinical Trials Register and updated daily.

CzechiaOur site in CzechiaKlinickeTesty.cz(opens in a new tab)
Prazske Predmesti at a glance
13
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

13 trials in Prazske Predmesti

Open in trial search
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Dextromethorphan Hydrobromide
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pelacarsen
  • Sponsor:Novartis Pharma AG
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Rotigotine
  • Sponsor:Fondazione Santa Lucia
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Octapharma Pharmazeutika Produktionsgesellschaft mbH
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:D-Prolyl-D-Threonyl-D-Leucyl-D-Histidyl-D-Threonyl-D-Histidyl-D-Asparaginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginyl-D-Arginine Amide Acetate
  • Sponsor:Prinnovation GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Migraine

Not recruiting
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum, Neurotoxin Serotype A/B
  • Sponsor:Ipsen Innovation
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Obicetrapib
  • Sponsor:NewAmsterdam Pharma B.V.

Migraine

Not recruiting
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Botulinum Toxin Type A - Haemagglutinin Complex
  • Sponsor:Ipsen Innovation
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ponsegromab
  • Sponsor:Pfizer Inc.
Investigational
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Mavacamten
  • Sponsor:Myokardia Inc.

Other cities in Czechia

The busiest research cities in the country

All 158 cities in Czechia

Clinical research in Prazske Predmesti

What the registry says about research in the country

01 Neurodegenerative Disorders

Innovative clinical research focusing on Alzheimer's disease, with multiple trials evaluating new therapeutic approaches. Studies include testing combinations of established medications like rivastigmine with novel compounds, and investigating new treatments for mild cognitive impairment (MCI).

  • Early-stage Alzheimer's treatment
  • Cognitive function improvement
  • Memory preservation strategies

Particular emphasis on developing treatments for patients with mild to moderate disease progression.

02 Cardiovascular Health

Comprehensive studies addressing various aspects of heart health, including chronic heart failure and atherosclerotic cardiovascular disease. Research focuses on innovative therapies to improve patient outcomes and quality of life.

  • Heart failure management
  • Atherosclerosis treatment
  • Cardiovascular risk reduction

Multiple trials evaluating new compounds for treating various cardiac conditions and their complications.

03 Specialized Cardiac Conditions

Advanced research into specific cardiac disorders, including calcific aortic valve stenosis and cardiomyopathy. Studies aim to evaluate novel treatments and their impact on disease progression and patient well-being.

  • Valve disease interventions
  • Cardiomyopathy management
  • Exercise capacity improvement

Focus on developing targeted therapies for complex cardiac conditions affecting specific patient populations.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.